Sign In

Also in this Section


  • To promote hepatitis C elimination through disease awareness, clinical education, research and advocacy.


  • To develop HCV educational programs for clinicians
  • To provide mentorship to junior SIG members from established members
  • To facilitate opportunities for SIG members to engage in advocacy
  • To promote disease awareness through social and digital media campaigns
  • To collaborate with international organizations engaged in HCV awareness, clinical care and elimination

SIG Leadership

  • Andrew Joseph Muir, MD, FAASLD
  • Nancy Reau, MD, FAASLD
  • Paul Yien Kwo, MD, FAASLD
  • Robert G. Gish, MD, FAASLD
    Steering Committee
  • Camilla S. Graham, MD, MPH
    Steering Committee
  • Donald M. Jensen, MD, FAASLD
    Steering Committee
  • Joseph K. Lim, MD, FAASLD
    Steering Committee
  • Jean-Michel Pawlotsky, MD, PhD, FAASLD
    Steering Committee
  • Bette Anne Preston
    Staff Liaison